Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Stress, alcohol and drug interaction: an update of human research.

Uhart M, Wand GS.

Addict Biol. 2009 Jan;14(1):43-64. doi: 10.1111/j.1369-1600.2008.00131.x. Epub 2008 Oct 9. Review.

2.

Relapse to drug-seeking: neural and molecular mechanisms.

Self DW, Nestler EJ.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):49-60. Review.

PMID:
9716929
3.

Drug dependence: stress and dysregulation of brain reward pathways.

Kreek MJ, Koob GF.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):23-47. Review. No abstract available.

PMID:
9716928
4.

Chronic stress, drug use, and vulnerability to addiction.

Sinha R.

Ann N Y Acad Sci. 2008 Oct;1141:105-30. doi: 10.1196/annals.1441.030. Review.

5.

Stress, dysregulation of drug reward pathways, and the transition to drug dependence.

Koob G, Kreek MJ.

Am J Psychiatry. 2007 Aug;164(8):1149-59. Review.

6.

HPA-axis activity in alcoholism: examples for a gene-environment interaction.

Clarke TK, Treutlein J, Zimmermann US, Kiefer F, Skowronek MH, Rietschel M, Mann K, Schumann G.

Addict Biol. 2008 Mar;13(1):1-14. Epub 2007 Oct 2. Review.

PMID:
17910738
7.
8.

Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.

Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F.

Brain Res. 2010 Feb 16;1314:145-61. doi: 10.1016/j.brainres.2009.12.027. Epub 2009 Dec 21. Review.

9.

The role of stress in addiction relapse.

Sinha R.

Curr Psychiatry Rep. 2007 Oct;9(5):388-95. Review.

PMID:
17915078
10.

Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.

George O, Le Moal M, Koob GF.

Physiol Behav. 2012 Apr 12;106(1):58-64. doi: 10.1016/j.physbeh.2011.11.004. Epub 2011 Nov 12. Review.

11.

Alcoholism: allostasis and beyond.

Koob GF.

Alcohol Clin Exp Res. 2003 Feb;27(2):232-43. Review.

PMID:
12605072
12.

The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders.

Stahl SM, Wise DD.

CNS Spectr. 2008 Jun;13(6):467-83. Review. No abstract available.

PMID:
18567971
13.

Brain stress systems in the amygdala and addiction.

Koob GF.

Brain Res. 2009 Oct 13;1293:61-75. doi: 10.1016/j.brainres.2009.03.038. Epub 2009 Mar 28. Review.

14.

Individual differences in prefrontal cortex function and the transition from drug use to drug dependence.

George O, Koob GF.

Neurosci Biobehav Rev. 2010 Nov;35(2):232-47. doi: 10.1016/j.neubiorev.2010.05.002. Epub 2010 May 20. Review.

15.

Drug addiction, dysregulation of reward, and allostasis.

Koob GF, Le Moal M.

Neuropsychopharmacology. 2001 Feb;24(2):97-129. Review.

16.

The neurobiology of stress and development.

Gunnar M, Quevedo K.

Annu Rev Psychol. 2007;58:145-73.

PMID:
16903808
17.
18.

Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Zhou Y, Proudnikov D, Yuferov V, Kreek MJ.

Brain Res. 2010 Feb 16;1314:235-52. doi: 10.1016/j.brainres.2009.11.015. Epub 2009 Nov 12. Review.

19.

Stress in adolescence and drugs of abuse in rodent models: role of dopamine, CRF, and HPA axis.

Burke AR, Miczek KA.

Psychopharmacology (Berl). 2014 Apr;231(8):1557-80. doi: 10.1007/s00213-013-3369-1. Epub 2013 Dec 27. Review.

20.

Sex differences in the neurobiology of drug addiction.

Bobzean SA, DeNobrega AK, Perrotti LI.

Exp Neurol. 2014 Sep;259:64-74. doi: 10.1016/j.expneurol.2014.01.022. Epub 2014 Feb 6. Review.

PMID:
24508560

Supplemental Content

Support Center